Update on the positive effects of light in humans

Photochemistry and Photobiology

Volumn 81, Issue 3, 2005, Pages 490-492

  Roberts, Joan E ^a  

^a FORDHAM UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MELATONIN;

CATARACT; CIRCADIAN RHYTHM; CONFERENCE PAPER; EYE; HUMAN; PHYSIOLOGY; RADIATION EXPOSURE; SUNLIGHT; VISUAL FIELD; VISUAL SYSTEM FUNCTION;

CATARACT; CIRCADIAN RHYTHM; EYE; HUMANS; MELATONIN; OCULAR PHYSIOLOGY; SUNLIGHT; VISUAL FIELDS;

EID: 21244487473     PISSN: 00318655     EISSN: None     Source Type: Journal    
DOI: 10.1562/2004-12-02-IR-391.1     Document Type: Conference Paper

References (38)

1. Roberts, J. E. (2001) Hazards of sunlight exposure to the eye. In Sun Protection in Man (Edited by Paolo U. Giacomoni), pp. 155-174. Elsevier, Amsterdam.
2. Ebrey, T. and Y. Koutalos (2001) Vertebrate photoreceptors. Prog. Retin. Eye Res. 20, 49-94.
3. Spudich, J. L., C. S. Yang, K. H. Jung and E. N. Spudich (2000) Retinylidene proteins: structures and functions from archaea to humans. Annu. Rev. Cell Dev. Biol. 16, 365-392.
4. Rattner, A., H. Sun and J. Nathans (1999) Molecular genetics of human retinal disease. Annu. Rev. Genet. 33, 89-131.
5. Redmond, T. M., S. Yu, E. Lee, D. Bok, D. Hamasaki, N. Chen, P. Goletz, J. X. Ma, R. K. Crouch and K. Pfeifer (1998) Rpe65 is necessary for production of 11-cis-vitamin A in the retinal visual cycle. Nat. Genet. 20, 344-351.
6. Moiseyev, G., R. K. Crouch, P. Goletz, J. Oatis, Jr., T. M. Redmond and J. X. Ma (2003) Retinyl esters are the substrate for isomer-ohydrolase. Biochemistry 42, 2229-2238.
7. Jahng, W. J., C. David, N. Nesnas, K. Nakanishi and R. R. Rando (2003) A cleavable affinity biotinylating agent reveals a retinoid binding role for RPE65. Biochemistry 42, 6159-6168.
8. Mata, N. L., W. N. Moghrabi, J. S. Lee, T. V. Bui, R. A. Radu, J. Horwitz and G. H. Travis (2004) Rpe65 is a retinyl ester binding protein that presents insoluble substrate to the isomerase in retinal pigment epithelial cells. J. Biol. Chem. 279, 635-643.
9. Fan, J., B. Rohrer, G. Moiseyev, J. X. Ma and R. K. Crouch (2003) Isorhodopsin rather than rhodopsin mediates rod function in RPE65 knock-out mice. Proc. Natl. Acad. Sci. USA 100, 13662-13667.
10. Pugh, E. N. (2001) Rods are rods and cones cones, and (never) the twain shall meet. Neuron 32, 375-376.
11. Ma, J., S. Znoiko, K. L. Othersen, J. C. Ryan, J. Das, T. Isayama, M. Kono, D. D. Oprian, D. W. Corson, M. C. Cornwall, D. A. Cameron, F. I. Harosi, C. L. Makino and R. K. Crouch (2001) A visual pigment expressed in both rod and cone photoreceptors. Neuron 32, 451-461.
12. Calkins, D. J. (2001) Seeing with S cones. Prog. Retin. Eye Res. 20, 255-287.
13. Hunt, D. M., J. A. Cowing, S. E. Wilkie, J. W. Parry, S. Poopalasundaram and J. K. Bowmaker (2004) Divergent mechanisms for the tuning of shortwave sensitive visual pigments in vertebrates. Photochem. Photobiol. Sci. 3, 713-720.
14. Fasick, J. I., M. L. Applebury and D. D. Oprian (2002) Spectral tuning in the mammalian short-wavelength sensitive cone pigments. Biochemistry 41, 6860-6865.
15. Roberts, J. E. (2000) Light and immunomodulation. Ann. NY Acad. Sci. 917, 435-445.
16. Berger, J. (2004) Regulation of circadian rhythms. J. Appl. Biomed. 2, 131-140.
17. Takahashi, J. S., P. J. DeCoursey, L. Bauman and M. Menaker (1984) Spectral sensitivity of a novel photoreceptive system mediating entrainment of mammalian circadian rhythms. Nature 308, 186-188.
18. Klein, D. C., R. Y. Moore and S. M. Reppert (1991) Suprachiasmatic Nucleus. The Mind's Clock. Oxford University Press, NY.
19. Lockley, S. W., D. J. Skene and J. Arendt (2000) Light and circadian rhythms in the blind. Abstract in 13th International Congress on Photobiology. 700.
20. Czeisler, C. A., T. L. Shanahan, E. B. Klerman, H. Martens, D. J. Brotman, J. S. Emens, T. Klein and J. F. Rizzo, 3rd (1995) Suppression of melatonin secretion in some blind patients by exposure to bright light. N. Engl. J. Med. 332, 6-11.
21. Berson, D. M., F. A. Dunn and M. Takao (2002) Phototransduction by retinal ganglion cells that set the circadian clock. Science 295, 1070-1073.
22. Hannibal, J., P. Hindersson, J. Ostergaard, B. Georg, S. Heegaard, P. J. Larsen and J. Fahrenkrug (2004) Melanopsin is expressed in PACAP-containing retinal ganglion cells of the human retinohypothalamic tract. Invest. Ophthalmol. Vis. Sci. 45, 4202-4209.
23. Foster, R. G. (2004) Seeing the light ... in a new way. J. Neuroendocrinol. 16, 179-180.
24. Panda, S., T. K. Sato, A. M. Castrucci, M. D. Rollag, W. J. DeGrip, J. B. Hogenesch, I. Provencio and S. A. Kay (2002) Melanopsin (Opn4) requirement for normal light-induced circadian phase shifting. Science 298, 2213-2216.
25. Rollag, M. D., D. M. Berson and I. Provencio (2003) Melanopsin, ganglion-cell photoreceptors, and mammalian photoentrainment. J. Biol. Rhythms 18, 227-234.
26. Brainard, G. C., J. P. Hanifin, J. M. Greeson, B. Byrne, G. Glickman, E. Gerner and M. D. Rollag (2001) Action spectrum for melatonin regulation in humans: evidence for a novel circadian photoreceptor. J. Neurosci. 21, 6405-6412.
27. Ablonczy, Z., R. M. Darrow, D. R. Knapp, D. T. Organisciak and R. K. Crouch (2005) Rhodopsin phosphorylation in rats exposed to intense light. Photochem. Photobiol. 81, 541-547.
28. Veitch, J. A., G. van den Beld, G. Brainard and J. E. Roberts (2004) Ocular lighting effects on human physiology and behavior. CIE 158, 1-50.
29. Roberts, J. E., R. Whitt, D. Lawless, J. S. Terman, M. Terman and J. Dillon (1992) Immune response to visible light treatment of SAD patients. In Biological Effects of Light (Edited by M. F. Holick and A. M Kligman), pp. 125-132. Walter de Gruyter, New York.
30. Levi, F., C. Canon, M. Dipalma, I. Florentin and J. L. Misset (1991) When should the immune clock be reset? From circadian pharmacodynamics to temporally optimized drug delivery. Ann. NY Acad. Sci. 618, 312-329.
31. Baldwin, W. S. and J. C. Barrett (1998) Melatonin: receptor-mediated events that may affect breast and other steroid hormone-dependent cancers. Mol. Carcinog. 21, 149-155.
32. Levi, F. (2000) Therapeutic implications of circadian rhythms in cancer patients. Novartis. Found. Symp. 227, 119-136; discussion 136-142.
33. Lissoni, P., S. Barni, A. Ardizzoia, F. Brivio, G. Tancini, A. Conti and G. J. Maestroni (1992) Immunological effects of a single evening subcutaneous injection of low-dose interleukin-2 in association with the pineal hormone melatonin in advanced cancer patients. J. Biol. Regul. Homeost. Agents 6, 132-136.
34. Maestroni, G. J. and A. Conti (1996) Melatonin and the immune-hematopoietic system therapeutic and adverse pharmacological correlates. Neuroimmunomodulation 3, 325-332.
35. Filipski, E., F. Delaunay, V. M. King, M. W. Wu, B. Claustrat, A. Grechez-Cassiau, C. Guettier, M. H. Hastings and L. Francis (2004) Effects of chronic jet lag on tumor progression in mice. Cancer Res. 64, 7879-7885.
36. Schernhammer, E. S., B. Rosner, W. C. Willett, F. Laden, G. A. Colditz and S. E. Hankinson (2004) Epidemiology of urinary melatonin in women and its relation to other hormones and night work. Cancer Epidemiol. Biomarkers Prev. 13, 936-943.
37. Pauley, S. M. (2004) Lighting for the human circadian clock: recent research indicates that lighting has become a public health issue. Med. Hypotheses 63, 588-596.
38. Conti, A. and G. J. Maestroni (1998) Melatonin rhythms in mice: role in autoimmune and lymphoproliferative diseases. Ann. NY Acad. Sci. 840, 395-410.